Holds 2 active US DMFs and one valid CEP for sotalol, filing since 2000. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF and one valid CEP for sotalol, filing since 1999. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for sotalol, filing since 1980. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds 2 active US DMFs for sotalol, filing since 1996. Its 2022 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one valid CEP for sotalol, filing since 2024. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for sotalol, filing since 2026.
Registered with DAV (Vietnam) for sotalol. Its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystContract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for sotalol and what filings they hold.
Chat with Fred, your AI analyst